Preclinical studies of melanoma and carcinogen-induced colorectal cancer suggested that sucralose consumption drove poor response to checkpoint inhibitors through microbial dysbiosis and downstream CD8+ T-cell dysfunction, a fundamental but not well-understood mechanism of ICI resistance. The gene discussed is CD8A; the disease is melanoma.